help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2280
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
92/7/2720    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meex, S. J. R.
Right arrow Articles by de Bruin, T. W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meex, S. J. R.
Right arrow Articles by de Bruin, T. W. A.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 7 2720-2725
Copyright © 2007 by The Endocrine Society

Activating Transcription Factor 6 Polymorphisms and Haplotypes Are Associated with Impaired Glucose Homeostasis and Type 2 Diabetes in Dutch Caucasians

Steven J. R. Meex, Marleen M. J. van Greevenbroek, Torik A. Ayoubi, Robert Vlietinck, Jana V. van Vliet-Ostaptchouk, Martin H. Hofker, Vicky M. M.-J. Vermeulen, Casper G. Schalkwijk, Edith J. M. Feskens, Jolanda M. A. Boer, Coen D. A. Stehouwer, Carla J. H. van der Kallen and Tjerk W. A. de Bruin

Cardiovascular Research Institute Maastricht, Department of Internal Medicine (S.J.R.M., M.M.J.v.G., V.M.M.-J.V., C.G.S., C.D.A.S., C.J.H.v.d.K., T.W.A.d.B.), Laboratory of Molecular Metabolism and Endocrinology, Department of Population Genetics (T.A.A., R.V.), Genomics and Bio-Informatics, and Department of Molecular Genetics (J.V.v.V.-O., M.H.H.), University of Maastricht, 6200 MD Maastricht, The Netherlands; Department of Human Genetics (R.V.), University of Leuven, Naamsestraat 69-3000 Leuven, Belgium; Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen and University of Groningen, 9700 RB Groningen, The Netherlands; Division of Human Nutrition (E.J.M.F.), Section of Nutrition and Epidemiology, Wageningen University, 6701 BH Wageningen, The Netherlands; Centre for Nutrition and Health, National Institute for Public Health and the Environment (J.M.A.B.), 3720 BA Bilthoven, The Netherlands; and GlaxoSmithKline (T.W.A.d.B.), Translational Medicine and Genetics, Research Triangle Park, North Carolina 27709

Address all correspondence and requests for reprints to: Steven Meex, Department of Internal Medicine, Laboratory of Molecular Metabolism and Endocrinology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E-mail: steven.meex{at}intmed.unimaas.nl.

Context: Activating transcription factor 6 (ATF6) is critical for initiation and full activation of the unfolded protein response. An association between genetic variation in ATF6 and type 2 diabetes (DM2) was recently reported in Pima Indians.

Objectives: To investigate the broader significance of this association for DM2, replication studies in distinct ethic populations are required. We investigated ATF6 for its association with DM2 in Dutch Caucasians.

Design/Setting: A genetic association study was conducted at an academic research laboratory.

Study Participants: Two independent Dutch cohorts were studied. Cohort 1 (n = 154) was used to evaluate genetic variation in the ATF6 gene in relation to glucose homeostasis in the general population. Cohort 2 (n = 798) consisted of patients with DM2, impaired glucose tolerance, impaired fasting glucose, and normoglycemic control subjects, and was used to investigate ATF6 polymorphisms for their contribution to disturbed glucose homeostasis and DM2.

Main Outcome Measures: There were 16 tag single nucleotide polymorphisms genotyped in all subjects of both cohorts. Those single nucleotide polymorphisms included three nonsynonymous coding variants and captured all common allelic variation of ATF6.

Results: Our data show that common ATF6 variants are associated with elevated glucose levels in the general population (cohort 1, P = 0.005–0.05). Furthermore, the majority of these variants, and haplotypes thereof, were significantly associated with impaired fasting glucose, impaired glucose tolerance, and DM2 (cohort 2, P = 0.006–0.05). Associated variants differ from those identified in Pima Indians.

Conclusions: Our results strengthen the evidence that one or more variants in ATF6 are associated with disturbed glucose homeostasis and DM2.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Scheuner and R. J. Kaufman
The Unfolded Protein Response: A Pathway That Links Insulin Demand with {beta}-Cell Failure and Diabetes
Endocr. Rev., May 1, 2008; 29(3): 317 - 333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society